Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals EPS Diluted (Quarterly) : 0.3068 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3068 |
| March 31, 2026 | 0.2446 |
| December 31, 2025 | -0.014 |
| September 30, 2025 | 0.2294 |
| June 30, 2025 | 0.1374 |
| March 31, 2025 | -0.2322 |
| December 31, 2024 | 0.0141 |
| September 30, 2024 | 0.0228 |
| June 30, 2024 | -0.0054 |
| March 31, 2024 | -0.0264 |
| December 31, 2023 | -0.007 |
| September 30, 2023 | 0.082 |
| June 30, 2023 | -6.837 |
| March 31, 2023 | 0.2508 |
| December 31, 2022 | 0.2639 |
| September 30, 2022 | 0.2788 |
| June 30, 2022 | 0.2066 |
| March 31, 2022 | 0.2047 |
| December 31, 2021 | 0.2498 |
| September 30, 2021 | 0.338 |
| June 30, 2021 | 2.393 |
| March 31, 2021 | 0.2459 |
| December 31, 2020 | 0.2675 |
| September 30, 2020 | 0.2148 |
| June 30, 2020 | 0.1576 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0209 |
| December 31, 2019 | 0.3031 |
| September 30, 2019 | 0.132 |
| June 30, 2019 | 0.0788 |
| March 31, 2019 | -0.3826 |
| December 31, 2018 | -0.1005 |
| September 30, 2018 | -1.138 |
| June 30, 2018 | -0.3245 |
| March 31, 2018 | -0.29 |
| December 31, 2017 | 0.08 |
| September 30, 2017 | -0.22 |
| June 30, 2017 | -0.30 |
| March 31, 2017 | -0.36 |
| December 31, 2016 | -0.09 |
| September 30, 2016 | -0.23 |
| June 30, 2016 | -0.15 |
| March 31, 2016 | -0.09 |
| December 31, 2015 | -0.0983 |
| September 30, 2015 | -0.33 |
| June 30, 2015 | -0.34 |
| March 31, 2015 | -0.24 |
| December 31, 2014 | -0.27 |
| September 30, 2014 | -0.30 |
| June 30, 2014 | -0.44 |
| March 31, 2014 | -0.38 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 2.033 |
| Rigel Pharmaceuticals, Inc. | 0.8835 |
| Marker Therapeutics, Inc. | -0.0946 |
| Verastem, Inc. | -0.3463 |
| Theriva Biologics, Inc. | -0.0701 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 51.29M |
| Revenue (Quarterly) | 113.04M |
| Total Expenses (Quarterly) | 61.75M |
| Enterprise Value | 1.027B |
| Gross Profit Margin (Quarterly) | 99.60% |
| Profit Margin (Quarterly) | 45.37% |
| Earnings Yield | 18.59% |
| Operating Earnings Yield | 33.96% |
| Normalized Earnings Yield | 18.77 |